发明名称 Polypeptides Having Xylanase Activity and Polynucleotides Encoding Same
摘要 The present invention provides isolated polypeptides having xylanase activity and polynucleotides encoding the polypeptides. The invention also provides nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
申请公布号 US2014220642(A1) 申请公布日期 2014.08.07
申请号 US201214346227 申请日期 2012.10.26
申请人 Novozymes Inc. 发明人 Tang Lan;Liu Ye;Zhang Yu;Duan Junxin
分类号 C12N9/24;C12P19/14 主分类号 C12N9/24
代理机构 代理人
主权项 1. An isolated polypeptide having xylanase activity, selected from the group consisting of: (a) a polypeptide having at least 60% sequence identity to the mature polypeptide of SEQ ID NO: 2; at least 65% sequence identity to the mature polypeptide of SEQ ID NO: 12; at least 70% sequence identity to the mature polypeptide of SEQ ID NO: 4 or SEQ ID NO: 10; at least 75% sequence identity to the mature polypeptide of SEQ ID NO: 14 or SEQ ID NO: 16; at least 80% sequence identity to the mature polypeptide of SEQ ID NO: 6 or SEQ ID NO: 8; at least 85% sequence identity to the mature polypeptide of SEQ ID NO: 20; or at least 90% sequence identity to the mature polypeptide of SEQ ID NO: 18; (b) a polypeptide encoded by a polynucleotide that hybridizes under at least medium-high stringency conditions with (i) the mature polypeptide coding sequence of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 9, or SEQ ID NO: 11, (ii) the cDNA sequence of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 9, or SEQ ID NO: 11, or (iii) the full-length complement of (i) or (ii); or at least high stringency conditions with (i) the mature polypeptide coding sequence of SEQ ID NO: 5, SEQ ID NO: 7, SEQ ID NO: 13, SEQ ID NO: 15, SEQ ID NO: 17, or SEQ ID NO: 19, (ii) the cDNA sequence of SEQ ID NO: 5, SEQ ID NO: 13, SEQ ID NO: 17, or SEQ ID NO: 19, or (iii) the full-length complement of (i) or (ii); (c) a polypeptide encoded by a polynucleotide having at least 60% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 1 or the cDNA sequence thereof; at least 65% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 11 or the cDNA sequence thereof; at least 70% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 3 or the cDNA sequence thereof or the mature polypeptide coding sequence of SEQ ID NO: 9 or the cDNA sequence thereof; at least 75% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 13 or the cDNA sequence thereof or the mature polypeptide coding sequence of SEQ ID NO: 15; at least 80% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 5 or the cDNA sequence thereof or the mature polypeptide coding sequence of SEQ ID NO: 7; at least 85% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 19 or the cDNA sequence thereof; or at least 90% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 17 or the cDNA sequence thereof; (d) a variant of the mature polypeptide of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 18, or SEQ ID NO: 20 comprising a substitution, deletion, and/or insertion at one or more (e.g., several) positions; and (e) a fragment of the polypeptide of (a), (b), (c), or (d) that has xylanase activity.
地址 Davis CA US